Notwithstanding, Hernandez et al. reported FGFR3 and TP53 mutations to be independently distributed in a large series of pT1G3 tumors, that were consequently interpreted as a particular group of bladder tumors that could not be classified into either one pathway or the other [4]. Here, TP53 is linked to urinary bladder neoplasm.